While some deals have still been closed and announced in the last few weeks, most have already been negotiated prior to the current health and economic crisis.
Many investors have put everything on hold and focus on supporting existing portfolio companies. Based on data from the 2008 crisis, it looks like valuations will be lower, investors will take more equity, and dictate terms that are more burdensome to startups. It is also likely that certain industries will be hit harder than others, while some will even benefit from the current situation as their products help to mitigate the impact of this crisis. This webinar will explain these dynamics and highlight what this could mean for German startups seeking to raise money in the US.
Marc Filerman, CEO, German Accelertor Life Sciences
Charlie Cameron, Founder & Managing Director, HUB Angels Investment Group
Christian Busch, CEO, German Accelerator New York, Angel Investor
Morgan Lai, Partner, Foundation Capital